弥合差距:将虚拟交叉匹配评估与移植后免疫学结果相关联
Carly J Amato-Menker1, Nadia Lewis1, Amber Paulus2
1Histocompatibility and Immunogenetics Laboratory, Virginia Commonwealth University, Richmond, VA, United States.
Human immunology
|November 29, 2025
概括
虚拟交叉匹配 (VXM) 是评估移植风险的可靠工具,与较少的不良事件和抗体介导排斥 (AMR) 相相关. 在大多数移植病例中,它是流交叉匹配 (FXM) 的安全替代品.
科学领域:
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
- 临床诊断 临床诊断 临床诊断
背景情况:
- 虚拟交叉匹配 (VXM) 是评估器官移植中的免疫风险的标准方法.
- 目前的验证往往侧重于与流量交叉匹配 (FXM) 的相关性,而不是临床结果.
研究的目的:
- 将VXM评估 (可接受与不可接受) 与移植后的结果进行比较,包括捐赠者特异性抗体 (DSA) 开发和抗体介导排斥 (AMR).
- 评估VXM作为移植中的FXM可靠替代品.
主要方法:
- 追溯分析将VXM状态与移植结果进行比较.
- 评估捐赠者特异性抗体 (DSA) 的发展和抗体介导排斥 (AMR).
- 比较VXM结果与并发流交叉匹配 (FXM) 结果.
主要成果:
- 一个可接受的VXM与更少的移植后不良事件相关.
- 接受不可接受VXMs的接受者具有显著更高的记忆HLA-DSA,AMR和与HLA-DSA相关的AMR.
- 在可接受的VXM和负面的FXM结果之间观察到很高的一致性 (94.4%).
结论:
- VXM是移植结果的可靠预测器,对于大多数移植接受者来说,它是FXM的合适替代品.
- 该VXM有效地识别了患有不良结果风险较高的患者,包括AMR.
- 确定了FXM可能仍然提供额外好处的特定场景.
相关概念视频
Tissue Transplantation
850
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
850
Drug Product Performance: In Vitro–In Vivo Correlation
206
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
206
Cell-mediated Immune Responses
83.2K
Overview
83.2K
Bone Marrow Sampling and Transplants
801
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
801


